Clinical Trials Specialist Panthera Biopartners Scoops Pharma Industry Award
October 11, 2023 – Other – Panthera Bio, awards
11 October 2023 — Preston, UK — After only four years since it was founded, Panthera Biopartners has been crowned ‘Pharma Research Centre of the Year’ at the prestigious Pharma Industry Awards UK 2023 in recognition of its innovative SMO (Site Management Organisation) model.
Founded in 2019 by Dr Ian Smith, founder of Synexus, and Professor John Lyon who was previously a global executive in CRO Covance, Panthera has updated the SMO model to focus on speed of start-up, access to more than a million patients – many prequalified – and digitisation of contact and qualification of patients and the running of clinical trials.
In ten clinical trials carried out in the last 18 months, Panthera has been the top recruiter in the UK, top recruiter globally, and has been the first to enrol a patient – key measures for clients.
Stuart Young, chief executive of Panthera commented, “This is a real tribute to our team, one of the most experienced in the industry, which has developed a new model which has attracted interest from pharma and CROs across the world. In just four years we have become the leading UK SMO.”
The Pharma Industry Awards UK identifies and celebrates the most original and innovative individuals and companies that demonstrate excellence in the UK pharma industry. Panthera was presented with the award at the official awards ceremony in Manchester on 28 September 2023.
About Panthera Bio
Panthera is a leading clinical trials organisation with dedicated clinical trial sites in locations around the UK, including Preston, Manchester, Glasgow and London. Our mission is to make clinical research more accessible to the general public. Our goals are to have a positive impact on healthcare within the UK and around the world by delivering clinical trials on behalf of the pharmaceutical industry. Panthera was founded in 2019 by Dr Ian Smith, who founded Synexus – the first SMO model – in Europe in 1989, and Professor John Lyon, a past global VP of CRO, Covance. They were joined by Jane Restorick, who was previously chief Operating officer and later chief patient officer at Synexus, and in 2020 Stuart Young, previously general manager of Synexus, joined Panthera to become CEO. In 2020 Chris Dodd, who was previously head of Commercial at Accelerated Enrolment Solutions, joined the team as chief commercial officer. Since 2019, and despite the COVID-19 pandemic, Panthera has grown to more than five sites across the UK with several more planned. Panthera has also formed a partnership with three sites in southern Sweden and is in discussion with further sites across Western Europe. Visit: www.panthera-bio.com.
